November 17, 2015 -
BioTect-ID is powered by the company’s patented software-only technology BioSig-ID, enabling the app to identify users by their unique drawing style as they write a four character password with their finger.
A BioTect-ID-protected system is extremely difficult to breach as hackers would have to accurately replicate the user’s drawing style in addition to knowing their password.
In a third party testing by the Tolly Group, the BioTect-ID technology was found to be 99.97% accurate at blocking fraudsters.
Not one of the 10,000 attempts by testers to bypass BioTect-ID were successful, despite being given the password to make it easier.
BioTect-ID exceeds National Institute for Standards for Technology (NIST) biometric accuracy standards by 300%, said the company.
“BioTect-ID is completely non-invasive,” said Jeff Maynard, CEO of Biometric Signature ID. “Physical biometrics like irises, fingerprints, and facial features are irreplaceable and gone forever if stolen. Drawing style is simply a gesture that can be revised or replaced any time.
“There’s no need to provide information about your body. We think that should stay private. Biometric identification will soon be a fact of life. As technologies compete, there is an urgent need for gesture biometrics like BioTect-ID which can’t be stolen, use no static physical information, and protect consumer body privacy without sacrificing accuracy.”
BioTect-ID’s inventive integration of a biometric with password knowledge makes it a multi-factor authentication app, the strongest security technology available for identity protection in mobile security applications. Because its dynamic biometric passwords can be easily replaced, BioTect-ID offers the first real alternative to physical biometrics with their potentially devastating consequences if stolen.
The White House recently selected BioSig-ID technology for a pilot program as part of NSTIC to generate secure online transactions by improving privacy and reducing the risk of fraud.
The 30-day Kickstarter campaign for BioTect-ID will initially seek development funding for the Android and iOS apps, with a consumer desktop version to be released at a future date.